High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol

Details 詳細情報について

• CRID

  1361137043594999936

• DOI

  10.1023/a:1008399623564

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419557477?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419557477?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/11/12/1585/19478031/11-12-1585.pdf

• Data Source

  • Crossref